Alexander et al. (III), “Synthesis and Antiviral Activity of Pyranosylphosphonic Acid Nucleotide Analogues,” Journal of Medicinal Chemistry, 39(6), 1321-1330 (Mar. 15, 1996).* |
Mansuri et al., “1-(2,3-Dideoxy-β-D-glycero-pent-2-enofuranosyl)thymine. A Highly Potent and Selective Anti-HIV Agent,” Journal of Medicinal Chemistry, 32(2), 461-466 (Feb., 1989).* |
McGuigan et al., “Aryl Phosphoramidate Derivatives of d4T Have Improved Anti-HIV Efficacy in Tissue Culture and May Act by the Generation of a Novel Intracellular Metabolite,” Journal of Medicinal Chemistry, 39(8), 1748-1753 (Apr. 12, 1996).* |
Siddiqui et al., “Design and Synthesis of Lipophilic Phosphoramidate d4T-MP Prodrugs Expressing High Potency Against HIV in Cell Culture: Structural Determinants for In Vitro Activity and QSAR,” Journal of Medicinal Chemistry, 42(20), 4122-4128 (1999); www publ. date of Sep. 21, 1999; see also Chemical Abstracts, 131(23), p. 519, Abstract No. 310 791b (Dec. 6, 1999).* |
Balzarini, J. et al, “Differential Patterns of Intracellular Metabolism of 2+, 3′-Didehydro-2′, 3′-dideoxythymidine and 3′-Azido-2′, 3′-dideoxythymidine, Two Potent Anti-human Immunodeficiency Virus Compounds”, J. Biol. Chem., 264(11):6127-6133 (Apr. 15, 1989). |
Bourinbaiar, A. et al., “Anti-HIV Effect of Gramicidin in Vitro: Potential for Spermicide Use”, Life Sciences, 54(1):PL5-9 (1994). |
Bourinbaiar, A. et al., “Comparative in vitro Study of Contraceptive Agents with Anti-HIV Activity: Gramicidin, nonoxynol-9, and gossypol”, Contraception, 49(2):131-137 (Feb. 1994). |
Burkman, L., “Discrimination Between Nonhyperactivated and Classical Hyperactivated Motility Patterns in Human Spermatozoa Using Computerized Analysis”, Fertility and Sterility, 55(2):363-371 (Feb. 1991). |
D'Cruz, O.J. et al., “Aryl Phosphate Derivatives of Bromo-Methoxy-Azidothymidine Are Dual-Function Spermicides with Potent Anti-Human Immunodeficiency Virus”, Biology of Reproduction, vol. 59, pp. 503-515 (1998). |
D'Cruz, O. et al., “β2-Integrin (CD11b/CD18) Is the Primary Adhesive Glycoprotein Complex Involved in Neutrophil-Mediated Immune Injury to Human Sperm”, Biology of Reproduction, 53(5):1118-1130 (Nov. 1995). |
D'Cruz, O. et al., “Spermicidal Activity of Metallocene Complexes Containing Vanadium (IV) in Humans”, Biology of Reproduction, 58(6):1515-1526 (Jun. 1998). |
Dicker, D. et al., “The Value of Repeat Hysteroscopic Evaluation in Patients with Failed in Vitro Fertilization Transfer Cycles”, Fertility and Sterility, 58(4):833-835 (Oct. 1992). |
Erice, A. et al., “Anti-Human Immunodeficiency Virus Type 1 Activity of an Anti-CD4 Immunoconjugate Containing Pokeweed Antiviral Protein”, Antimicrobial Agents and Chemotherapy, 37(4):835-838 (Apr. 1993). |
Erlandsen, S. et al., “Membrane Fixation for High-Resolution Low-Voltage SEM: Studies in Giardia, Rat Spermatozoa, and Mouse Macrophages”, Scanning, 11(4) 169-175 (Jul./Aug. 1989). |
Furman, P. et al, “Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with Human Immunodeficiency Virus Reverse Transcriptase”, Proc. Natl. Acad. Sci. USA, vol. 83, pp. 8333-8337 (Nov. 1986). |
Hao, Z. et al., “Factors Determining the Activity of 2′,3′-Dideoxynucleosides in Suppressing Human Immunodeficiency Virus In Vitro”, Molecular Pharmacology, 34(4):431-435 (Oct. 1988). |
Jan, S. T. et al., “Synthesis of dual function (5R,6R)- and (5S, 6S)-5-bromo-6-methoxy-5, 6-dihydro-AZT-5′-(para-bromophenyl methoxyalaninyl phosphate) as novel spermicidal and anti-HIV agents”, Antiviral Chemistry & Chemotherapy, vol. 10, pp. 39-46 (Jul. 9, 1999). |
Kumar, R. et al., “Synthesis, In Vitro Biological Stability, and Anti-HIV Activity of 5-Halo-6-alkoxy (or azido)-5, 6-dihydro-3′-azido-3′-deoxythymidine Diastereomers as Potential Prodrugs to 3′-Azido-3′-deoxythymidine (AZT)”, J. Med. Chem., 37(25):4297-4306 (Dec. 9, 1994). |
McGuigan, C. et al., “Aryl Phosphate Derivatives of AZT Inhibit HIV Replication in Cells Where the Nucleoside is Poorly Active”, Bioorganic & Medicinal Chemistry Letters, 2(7):701-704 (1992). |
McGuigan, C. et al., “Aryl Phosphate Derivatives of AZT Retain Activity Against HIV1 in Cell Lines Which are Resistant to the Action of AZT”, Antiviral Research, 17(4):311-321 (Apr. 1, 1992). |
McGuigan, C. et al., “Intracellular Delivery of Bioactive AZT Nucleotides by Aryl Phosphate Derivatives of AZT”, J. Med. Chem., 36(8):1048-1052 (Apr. 16, 1993). |
McGuigan, C. et al., “Phosphoramidates as Potent Prodrugs of Anti-HIV Nucleotides: Studies in the Amino Region”, Antiviral Chemistry & Chemotherapy, 7(1):31-36 (1996). |
McGuigan, C. et al., “Phosphoramidate Derivatives of AZT as Inhibitors of HIV. Studies on the Carboxyl Terminus”, Antiviral Chemistry & Chemotherapy, 4(2):97-101 (1993). |
McGuigan, C. et al., “Phosphoramidate Derivatives of d4T with Improved Anti-HIV Efficacy Retain Full Activity in Thymidine Kinase-Deficient Cells”, Bioorganic & Medicinal Chemistry Letters, 6(10):1183-1186 (May 21, 1996). |
McIntee, E. et al., “Probing the Mechanism of Action and Decomposition of Amino Acid Phosphomonoester Amidates of Antiviral Nucleoside Prodrugs”, J. Med. Chem., 40(21):3323-3331 (Oct. 10, 1997). |
Niruthisard, S. et al., “The Effects of Frequent Nonoxynol-9 Use on the Vaginal and Cervical Mucosa”, Sexually Transmitted Diseases, 18(3):176-179 (Jul.-Sep. 1991). |
Siddiqui, A. et al., “The Presence of Substituents on the Aryl Moiety of the Aryl Phosphoramidite Derivative of d4T Enhances Anti-HIV Efficacy in Cell Culture: A Structure—Activity Relationship”, J. Med. Chem., 42:393-399 (1999). |
Stoffel, M. et al., “Improved Preservation of Rat Epididymal Sperm for High-Resolution Low-Voltage Scanning Electron Microscopy (HR-LVSEM)”, Molecular Reproduction and Development, 34(2):172-182 (Feb. 1993). |
Tryphonas, L. et al., “Morphologic Evidence for Vaginal Toxicity of Delfen Contraceptive Cream in the Rat”, Toxicology Letters, 20(3):289-295 (Mar. 1984). |
Uckum, F. et al., “TXU (Anti-CD7)—Pokeweed Antiviral Protein as a Potent Inhibitor of Human Immunodeficiency Virus”, Antimicrobial Agents & Chemotherapy, 42(2):383-388 (Feb. 1998). |
Vig, R. et al., “D4T-5′[p-Bromophenyl Methoxyalaninyl Phosphate] as a Potent and Non-Toxic Anti-Human Immunodeficiency Virus Agent”, Antiviral Chem. Chemother., vol. 9(5), pp. 445-448 (1998). |
Wang, L. et al., “In Vivo Biodistribution, Pharmacokinetic Parameters, and Brain Uptake of 5-Halo-6-methory (or ethoxy)-5, 6-dihydro-3′-azido-3′-deoxythymidine Diastereomers as Potential Prodrugs of 3′-Azido-3′-deoxythymidine”, J. Med. Chem., 39(4):826-833 (Feb. 16, 1996). |
Wiebe, L. et al., “5-Halo-6-alkoxy-5, 6-dihydro-pyrimidine Nucleosides: Antiviral Nucleosides or Nucleoside Prodrugs”, Nucleosides & Nucleotides, 14(3-5):501-505 (May/Jun./Jul. 1995). |
Wilborn, W. et al., “Scanning Electron Microscopy of Human Spermatozoa after Incubation with the Spermicide Nonoxynol-9”, Fertility and Sterility, 39(5):717-719 (May 1983). |
Zarling, J. et al., “Inhibition of HIV Replication by Pokeweed Antiviral Protein Targeted to CD4+ Cells by Monoclonal Antibodies”, Nature 347(6288):92-95 (Sep. 6, 1990). |
Jan, S. et al., “AZT-5′-(p-bromophenyl methoxyalaninyl phosphate) as a potent and non-toxic anti-human immunodeficiency virus agent,” Antiviral Chemistry & Chemotherapy, vol. 10, pp. 47-52 ©1999 International Medical Press). |
Venkatachalam, T. K. et al., “Enhancing Effects of a Mono-Bromo Substitution at the Para Position of the Phenyl Moiety on the Metabolism and Anti-HIV Activity of D4T-Phenyl Methoxyalaninyl Phosphate Derivatives,” Bioorganic & Medicinal Chemistry Letters, vol. 8, pp. 3121-3126 (1998). |
Vig. R. et al., “Aryl phosphate derivatives of 3′-dioxythymidine are not potent anti-human immunodeficiency virus agents,” Antiviral Chemistry & Chemotherapy, vol. 9, pp. 439-443 ©1998 International Medical Press). |